46040 Federal Register / Vol. 72, No. 158 / Thursday, August 16, 2007 / Notices 

Military Health Care, a duly established 

subcommittee of the Defense Health 

Board. 

DATE OF MEETING: September 5, 2007. 

TIME OF MEETING: 9 a.m. to 3 p.m. 

PLACE OF MEETING: National 

Transportation Safety Board Conference 

Center, 429 L’Enfant Plaza, Washington, 

DC 20594. 

PURPOSE OF MEETING: To obtain, review, 

and evaluate information related to the 

Task force’s congressionally directed 

mission to examine matters relating to 

the future of military health care. The 

Task Force members will receive 

briefings on topics related to the 

delivery of military health care during 

the public meeting. 

AGENDA: Discussion topic will be 

Command and Control of the Military 

Health Care System. 

Prior to the public meeting the Task 

Force will conduct a Preparatory Work 

Meeting from 8 a.m.–8:50 a.m. to solely 

analyze relevant issues and facts in 

preparation for the Task Force’s next 

public meeting. In addition, the Task 

Force, following its public meeting, will 

conduct an additional Preparatory Work 

Meeting from 3:10 p.m. to 4 p.m. to 

analyze relevant issues and facts in 

preparation for the Task Force’s next 

public meeting. Both Preparatory 

Meetings will be held at the National 

Transportation Safety Board Conference 

Center, and pursuant to 41 Code of 

Federal Regulations, Part 102–3.160(a). 

Both Preparatory Work Meetings are 

closed to the public. 

Additional information and meeting 

registration is available online at the 

Task Force Web site: 

www.DoDfuturehealthcare.net. 

FOR FURTHER INFORMATION CONTACT: 

Colonel Christine Bader, Executive 

Secretary, Department of Defense Task 

Force on the Future of Military Health 

Care, TMA/Code: DHS, Five Skyline 

Place, Suite 810, 5111 Leesburg Pike, 

Falls Church, Virginia 22041–3206, 

(703) 681–3279, ext. 109 

(christine.bader@ha.osd.mil). 

SUPPLEMENTARY INFORMATION: Open 

sessions of the meeting will be limited 

by space accomodations. Any interested 

person may attend; however, seating is 

limited to the space available at the 

National Transportation Safety Board 

Conference Center. Individuals or 

organizations wishing to submit written 

comments for consideration by the Task 

Force should provide their comments in 

an electronic (PDF Format) document 

through the Task Force Web site (http:// 

DoDfuturehealthcare.net) at the 

‘‘Contact Us’’ page, no later than five (5) 

business days prior to the scheduled 

meeting. 

Dated: August 13, 2007. 

L.M. Bynum, 

Alternate OSD Federal Register Liaison 

Officer, Department of Defense. 

[FR Doc. 07–4027 Filed 8–14–07; 10:27 am] 

BILLING CODE 5001–06–M 

DEPARTMENT OF DEFENSE 

Office of the Secretary 

Sunshine Act Meeting of the Uniform 

Formulary Beneficiary Advisory Panel 

AGENCY: Department of Defense, 

Assistant Secretary of Defense (Health 

Affairs). 

ACTION: Notice of meeting. 

SUMMARY: Under the provisions of the 

Federal Advisory Committee Act of 

1972 (5 U.S.C., Appendix, as amended) 

and the Sunshine in the Government 

Act of 1976 (U.S.C. 552b, as amended) 

the Department of Defense announces 

the following Federal Advisory 

Committee Meeting: 

NAME OF COMMITTEE: Uniform Formulary 

Beneficiary Advisory Panel (hereafter 

referred to as the Panel). 

DATE OF MEETING: Tuesday, September 

18, 2007. 

LOCATION: Naval Heritage Center 

Theater, 701 Pennsylvania Avenue, 

NW., Washington, DC 20004. 

TIME: 8 a.m. to 4 p.m. 

PURPOSE OF MEETING: The Panel will 

review and comment on 

recommendations made to the Director, 

TRICARE Management Activity, by the 

Pharmacy and Therapeutics (P&T) 

Committee regarding the Uniform 

Formulary. 

MEETING AGENDA: Sign-In; Welcome and 

Opening Remarks; Opportunity for 

Public Citizen Comments; Scheduled 

Therapeutic Class Review—

(Leukotriene Modifying Agents (LMAs), 

Growth Stimulating Agents (GSAs), 

Second Generation (newer) 

Antihistamines (SGAs) and Designated 

newly Approved Drugs; Panel 

discussions, vote, and comments 

following each therapeutic class review. 

MEETING ACCESSIBILITY: Pursuant to 5 

U.S.C. 552b, as amended, and 41 CFR 

102–3.140 through 102–3.165, and the 

availability of space this meeting is 

open to the public. Seating is limited 

and will be provided only to the first 

220 people signing in. All persons must 

sign in legibly. 

WRITTEN STATEMENTS: Pursuant to 41 

CFR 102–3.105(j) and 102–3.140, the 

public or interested organizations may 

submit written statements to the 

membership of the Panel at any time or 

in response to the stated agenda of a 

planned meeting. Written statements 

should be submitted to the Panel’s 

Designated Federal Officer. The 

Designated Federal Officer’s contact 

information can be obtained from the 

GSA’s FACA Database—https:// 

www.fido.gov/facadatabase/public.asp. 

Written statements that do not pertain 

to the scheduled meeting of the Panel 

may be submitted at any time. However, 

if individual comments pertain to a 

specific topic being discussed at a 

planned meeting then these statements 

must be submitted no later than five (5) 

business days prior to the meeting in 

question. The Designated Federal 

Officer will review all submitted written 

statements and provide copies to all the 

committee members. 

PUBLIC COMMENTS: In addition to written 

statements, the Panel will set aside one 

(1) hour for individual or interested 

groups to address the Panel. To ensure 

consideration of their comments, 

individuals and interested groups 

should submit written statements as 

outlined in this notice. Additionally, 

they will be afforded the opportunity to 

address the Panel. Registration for 

addressing the Panel in on a first-come, 

first-serve basis. Those wishing to 

address the Panel will be given no more 

than five (5) minutes to present their 

comments, and at the end of the one (1) 

hour time period no further public 

comments will be accepted. 

FOR FURTHER INFORMATION CONTACT: 

Major Travis Watson, Designated 

Federal Officer, Uniform Formulary 

Beneficiary Advisory Panel, Skyline 5, 

Suite 810–5111 Leesburg Pike, Falls 

Church, Virginia 22041–3206, 

Telephone: (703) 681–2890—Fax: (703) 

681–1940, E-mail Address: 

baprequests@tma.osd.mil. 

Dated: August 13, 2007. 

L.M. Bynum, 

Alternate OSD Federal Register Liaison 

Officer. 

[FR Doc. 07–4028 Filed 8–14–07; 10:27 am] 

BILLING CODE 5001–06–M 

DEPARTMENT OF DEFENSE 

Office of the Secretary 

[DoD–2007–OS–0088] 

Privacy Act of 1974; Systems of 

Records 

AGENCY: Defense Finance and 

Accounting Service, DOD. 

ACTION: Notice to add a system of 

records. 


rwilkins on PROD1PC63 with NOTICES